🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrew Quon

University of California, Los Angeles

ORCID: 0000-0003-4011-3387

Also affiliated with Los Angeles Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer”.

Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer

Journal of Clinical Oncology(2024)10.1200/jco.24.00022
N/A
1.1DataRank · unranked
39 citations

Chen Hu, Daniel A. Pryma, Fenghai Duan, M.M. Matuszak, Ying Xiao +22 more

A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1345
N/A
0.851DataRank · unranked
22 citations

Fangxin Hong, Thomas M. Habermann, Ranjana H. Advani, Randy D. Gascoyne, Thomas E. Witzig +11 more

Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262543
N/A
0DataRank · unranked
37 citations

Johannes Czernin, Pan Thin, J Gartmann, Kathleen Nguyen, Wesley R. Armstrong +14 more

Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408

Blood Neoplasia(2025)10.1016/j.bneo.2025.100113
N/A
0DataRank · unranked
1 citations

Stephen M. Broski, Zequn Sun, Masha Kocherginsky, Betsy LaPlant, Matthew J. Maurer +10 more